SGX:BSLHealthcare
Raffles Medical Group (SGX:BSL) Margin Improvement To 9.2% Tests Bearish Earnings Narratives
Raffles Medical Group (SGX:BSL) posts FY 2025 first half results
Raffles Medical Group (SGX:BSL) has posted FY 2025 first half revenue of S$378.4 million with basic EPS of S$0.01732, setting the tone for its latest earnings update. The company has seen revenue move from S$365.7 million in 1H 2024 to S$386.7 million in 2H 2024 and S$378.4 million in 1H 2025, while basic EPS tracked from S$0.0165 to S$0.017008 and then S$0.01732 over the same periods, supported by trailing 12 month net income...